Gosindai Gospel Hospital has obtained certification from the Ministry of Health and Welfare's Institutional Review Board (IRB).

Gosindai Gospel Hospital has obtained certification from the Ministry of Health and Welfare's Institutional Review Board (IRB).

View original image

[Asia Economy Yeongnam Reporting Headquarters Reporter Dongguk Lee] Kosin University Gospel Hospital has obtained final certification in the 2021 ‘Institutional Review Board (IRB) Evaluation and Certification’ from the Ministry of Health and Welfare.


The certification is valid for three years (March 11, 2022 ? March 10, 2025).


The ‘Institutional Review Board Evaluation and Certification’ is conducted by the National Bioethics Policy Institute, which forms a review committee to assess the capabilities of each institutional review board, with final approval granted by the Minister of Health and Welfare. Among 311 institutions evaluated in the first cycle, 27 institutions that met the appropriateness of IRB composition and operation received certification.


The Clinical Trial and Medical Research Ethics Review Committee (hereinafter IRB) at Kosin University Gospel Hospital passed all 40 evaluation criteria across five categories, including the creation of an ethical research environment meeting international standards and quality management of the institutional committee, through document and on-site evaluations conducted from February 2021 to January 2022, thereby solidifying its status as a committee conducting research.


Through the Ministry of Health and Welfare’s Institutional Review Board Evaluation and Certification, it was certified that the committee complies with domestic and international laws and performs review tasks that meet the standards.


Professor Taewon Jang (IRB Chair) stated, “The Kosin University Hospital IRB will continue to make every effort to protect research subjects and create a scientific and ethical research environment.”


Director Kyungseung Oh of Gospel Hospital said, “With the Institutional Review Board Evaluation and Certification, we can more thoroughly review the ethical, scientific, and medical aspects of research, and maintain high-quality capabilities that align with patients’ rights, laws, and ethical standards.”

They are taking a commemorative photo after the Institutional Review Board (IRB) evaluation certification plaque ceremony.

They are taking a commemorative photo after the Institutional Review Board (IRB) evaluation certification plaque ceremony.

View original image

The IRB is an autonomous and independent committee authorized under the ‘Bioethics and Safety Act’ to review the ethical, scientific, and medical aspects of clinical research involving research subjects, ensuring their rights, safety, and welfare, and to approve research plans. It also performs investigation and supervision functions regarding the research process and results, such as verifying whether appropriate consent was obtained from research subjects to secure bioethics and safety.



The ‘Institutional Review Board Evaluation and Certification System’ is a system that regularly evaluates and certifies the composition and operational performance of institutional review boards based on the ‘Bioethics and Safety Act’ to enhance the quality of institutional committees, create an ethical research environment that meets international standards, and secure the capability to protect research subjects. After a pilot project (2013?2020), it was converted into an official certification system in 2021 and is conducted by the National Bioethics Policy Institute under the supervision of the Ministry of Health and Welfare.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing